News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,191 Results
Type
Article (14329)
Company Profile (106)
Press Release (259748)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88344)
Career Advice (467)
Deals (15399)
Drug Delivery (75)
Drug Development (36791)
Employer Resources (50)
FDA (6385)
Job Trends (6244)
News (150858)
Policy (14142)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (450)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23348)
ALS (57)
Alzheimer's disease (488)
Antibody-drug conjugate (ADC) (99)
Approvals (6577)
Artificial intelligence (202)
Autoimmune disease (41)
Automation (13)
Bankruptcy (150)
Best Places to Work (4382)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (41)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (171)
Cancer (1318)
Cardiovascular disease (151)
Career advice (420)
Career pathing (13)
CAR-T (52)
CDC (6)
Cell therapy (156)
Cervical cancer (9)
Clinical research (32072)
Collaboration (731)
Compensation (325)
Complete response letters (33)
COVID-19 (779)
CRISPR (43)
C-suite (434)
Cystic fibrosis (59)
Data (1829)
Denatured (18)
Depression (45)
Diabetes (126)
Diagnostics (1383)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (114)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (80)
Earnings (33476)
Editorial (20)
Employer branding (4)
Employer resources (45)
Events (39032)
Executive appointments (528)
FDA (7486)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (430)
Gene editing (70)
Generative AI (18)
Gene therapy (170)
GLP-1 (439)
Government (1404)
Grass and pollen (4)
Guidances (164)
Healthcare (3586)
HIV (12)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (69)
Immuno-oncology (14)
Indications (53)
Infectious disease (843)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (61)
IPO (5914)
IRA (33)
Job creations (2056)
Job search strategy (376)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (206)
Leadership (8)
Legal (3450)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (420)
MASH (67)
Medical device (1309)
Medtech (1316)
Mergers & acquisitions (9903)
Metabolic disorders (434)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (86)
Neuropsychiatric disorders (37)
Neuroscience (900)
Neurotech (1)
NextGen: Class of 2026 (1594)
Non-profit (605)
Now hiring (17)
Obesity (227)
Opinion (142)
Ovarian cancer (39)
Pain (109)
Pancreatic cancer (51)
Parkinson's disease (80)
Partnered (11)
Patents (221)
Patient recruitment (116)
Peanut (12)
People (29765)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8317)
Phase 2 (13529)
Phase 3 (12247)
Pipeline (1909)
Policy (136)
Postmarket research (1401)
Preclinical (3352)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (352)
Real estate (2663)
Recruiting (18)
Regulatory (10969)
Reports (15)
Research institute (577)
Resumes & cover letters (55)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (69)
Series A (80)
Series B (48)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1645)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (232)
Venture capital (32)
Weight loss (140)
Women's health (27)
Worklife (4)
Date
Last 7 days (178)
Last 30 days (710)
Last 365 days (10438)
2026 (961)
2025 (10739)
2024 (12520)
2023 (14272)
2022 (19598)
2021 (20099)
2020 (19047)
2019 (14925)
2018 (11745)
2017 (13904)
2016 (13146)
2015 (15485)
2014 (12429)
2013 (10604)
2012 (11408)
2011 (11932)
2010 (10902)
Location
Africa (318)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20896)
Australia (2689)
California (3185)
Canada (1483)
China (551)
Colorado (143)
Connecticut (129)
Delaware (123)
Europe (40968)
Florida (601)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (348)
India (44)
Indiana (240)
Iowa (2)
Japan (246)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (423)
Massachusetts (2592)
Michigan (46)
Minnesota (165)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1397)
New Mexico (7)
New York (907)
North Carolina (619)
North Dakota (2)
Northern California (1454)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (719)
Puerto Rico (12)
Rhode Island (17)
South America (508)
South Carolina (10)
Southern California (1388)
Tennessee (53)
Texas (454)
United States (12692)
Utah (59)
Virginia (160)
Washington D.C. (42)
Washington State (226)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
274,191 Results for "shuttle pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Shuttle Executes LOI with Molecule.ai
October 13, 2025
·
4 min read
Press Releases
Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)
October 23, 2025
·
7 min read
Press Releases
Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)
October 21, 2025
·
8 min read
Press Releases
Shuttle Pharma Provides Second Quarter 2025 Corporate Update
August 15, 2025
·
5 min read
Press Releases
Manifold Bio Announces Strategic Collaboration with Roche to Develop Multiple Next-Generation Brain Shuttles for Neurological Diseases
November 4, 2025
·
5 min read
Press Releases
Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)
October 23, 2025
·
7 min read
Press Releases
Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market
June 25, 2025
·
3 min read
Press Releases
Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market
June 23, 2025
·
3 min read
Press Releases
Shuttle Pharma Provides Corporate Update
May 15, 2025
·
5 min read
Alzheimer’s disease
Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro
The deal will see Novartis gain global rights over SciNeuro’s potentially disease-modifying anti-amyloid antibody, which leverages the latter’s proprietary shuttle platform to allow delivery into the brain.
January 12, 2026
·
2 min read
·
Tristan Manalac
1 of 27,420
Next
